GlobalData Pharma provides access to a compilation of drug data across the R&D lifecycle from discovery and clinical development through regulatory submission and commercialization. This database presents a holistic view of pharmaceutical companies and the and indications drug landscape. It combines a vast amount of data related to drug development processes, clinical trials, regulatory affairs, and market dynamics from around the world; it also includes a broad array of therapeutic areas to identify trends and potential opportunities in the market.
Login and select the Pharma Intelligence Center (IC). One in, browse the top menu bar (suggested search strategy) or search by keyword in the top right of the page.
Use GlobalData Pharma to access information about:
- Companies: Information about leading pharmaceutical companies from around the world. The database has information on past and current acquisitions and mergers.
- Drug Profiles: Includes detailed information about pipeline drugs, clinical trials, regulatory milestones, biomarkers, and social media analytics, including mechanisms of action, indications, stages of development, and regulatory status.
- Clinical Trials: Data on ongoing and completed clinical trials, including study design, endpoints, and results, helping users identify trends and emerging therapies.
- Market Analysis: Insights into market size, forecast data, competitive dynamics, and key players in various therapeutic areas.
- Pipelines: An overview of drugs in development across different stages, researchers can track new entrants and advancements in the market.
- Commercial Insights: Analyze market access strategies, pricing, and reimbursement landscape, providing a perspective on how drugs can be successfully launched and adopted.
- Therapeutic Areas: Combines classification of drugs by therapeutic areas, supporting the understanding of market needs and emerging prospects.
- Countries: Performance and potential of the most important territories through each of the country-specific lenses below.
